CANADA RETALIATES............

Discussion in 'Wall St. News' started by S2007S, Mar 4, 2025.

  1. Europe getting ready to escalate with their own counters. Everyone better buckle-up!
     
    #201     Apr 3, 2025
  2. maxinger

    maxinger

    Canada & EU retaliation wouldn't hurt much to the US.

    Watch out what China the next superpower is going to do.
    China can easily stop selling rare earth, active pharmaceutical ingredients API ... to the US.
    China is on holiday now. So their retaliation wouldn't start until earliest next week.
     
    Last edited: Apr 3, 2025
    #202     Apr 3, 2025
  3. I'm already planning ahead a few steps, for the counter to the counter to the counter to the counter tariffs.

    This isn't ending well I'm afraid.
     
    #203     Apr 3, 2025
  4. vztrdr

    vztrdr

    Speaking of a (now exponentially) evolving tech that needs to be on the radar:
    Robotic Exoskeletons....

    https://www.sciencedirect.com/topics/engineering/exoskeleton-robotics

    There's a few penny stocks out there now that are primarily serving the physical rehab market, and Lockheed is developing military uses, but this stuff will have far broader applications going forward as AI and non-invasive sensors that can isolate certain brainwaves become better and better.

    Which one of those penny stocks holds the most (best) patents? This is going to be a rapidly growing industry. I could see someone like BSX scooping up one of these pennies if they own cutting edge IP.
    I'll have to dig deeper.
     
  5. vztrdr

    vztrdr

    AI Search:

    Which publicly traded company specializing in exoskeletons has the most valuable patents

    Web29 sources1 languages
    Answer completed

    To determine which publicly traded company specializing in exoskeletons holds the most valuable patents, we can analyze the current landscape of exoskeleton technology and the companies involved.
    Key Players in the Exoskeleton Market

    Ekso Bionics: This company is a leader in the exoskeleton market, known for its innovative robotic exoskeletons designed for rehabilitation and mobility enhancement. Ekso Bionics has received FDA clearance for several of its products, including the EksoNR, which is aimed at patients with neurological conditions like multiple sclerosis. The company is publicly traded on NASDAQ under the ticker symbol EKSO

    .

    ReWalk Robotics: Another significant player, ReWalk focuses on exoskeletons that assist individuals with spinal cord injuries. Their products are designed to enable users to stand, walk, and climb stairs. ReWalk is also publicly traded on NASDAQ under the ticker RWLK

    .

    CYBERDYNE: Based in Japan, CYBERDYNE is known for its HAL (Hybrid Assistive Limb) exoskeleton, which is used in both medical and industrial applications. The company is publicly traded on the Tokyo Stock Exchange under the ticker 7779

    .

    Patent Valuation and Impact

    The value of patents can be assessed through various factors, including the breadth of coverage, the technology's applicability, and the potential market impact.

    Ekso Bionics has a robust patent portfolio that includes patents for its rehabilitation technologies, which are critical for its competitive edge in the medical market. The company’s patents cover various aspects of exoskeleton technology, enhancing its market position and potential revenue streams

    .

    ReWalk Robotics also holds valuable patents related to its unique approach to exoskeleton design, which focuses on user-friendly interfaces and mobility solutions for individuals with disabilities. Their patents are essential for maintaining their market share and advancing their technology

    .

    CYBERDYNE has developed a significant number of patents related to its HAL technology, which is recognized for its innovative approach to assistive robotics. The company's patents are crucial for its operations and expansion into new markets

    .

    Conclusion

    While all three companies—Ekso Bionics, ReWalk Robotics, and CYBERDYNE—hold valuable patents, Ekso Bionics appears to have the most comprehensive and impactful patent portfolio, particularly due to its FDA-approved products and ongoing innovations in rehabilitation technology. This positions Ekso Bionics as a leader in the exoskeleton market, both in terms of technological advancement and potential market value.
     
  6. vztrdr

    vztrdr

    Ekso Bionics Holdings Inc ---> $0.45
    Pretty small. Some cash-burn.
    Nice website though.

    https://eksobionics.com/eksoworks/

    Hmph... this is exactly what I was thinking...

    Ekso EVO has countless applications

    Solar installation
    Utilities and telecommunications
    Logistics and fulfillment
    Automotive mechanics
    Food processing
    Drywall installation
    Shipbuilding
    Film equipment operation
    Natural gas & oil
    HVAC installation & repair
    Plastering